TISSEEL KIT VH 0.5
TISSEEL KIT VH 0.5
Discontinued
DIN Number
02233272
Drug Class
Human
Market Date
Jan 20, 1998
Company
HC
Baxter AG
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02233272
AIG Number0936991007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B02BC30 COMBINATIONS
Product Specifications
Dosage FormPowder For Solution
,
Liquid
,
Kit
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (9)
APROTININ (BOVINE)Active
Strength: 0.5 ML / VIAL
Monograph: APROTININ (BOVINE)
CALCIUM CHLORIDEActive
Strength: 0.5 ML / VIAL
Monograph: CALCIUM CHLORIDE
FACTOR XIIIActive
Strength: 25 UNIT / VIAL
Monograph: FACTOR XIII
FIBRINOGEN (HUMAN)Active
Strength: 55 MG / VIAL
Monograph: FIBRINOGEN (HUMAN)
PLASMAFIBRONECTIN (CIG)Active
Strength: 4.5 MG / VIAL
Monograph: PLASMAFIBRONECTIN (CIG)
PLASMINOGENActive
Strength: 60 MCG / VIAL
Monograph: PLASMINOGEN
THROMBIN (HUMAN)Active
Strength: 2 UNIT / VIAL
Monograph: THROMBIN (HUMAN)
THROMBIN (HUMAN)Active
Strength: 250 UNIT / VIAL
Monograph: THROMBIN (HUMAN)
TOTAL PROTEINActive
Strength: 65 MG / VIAL
Monograph: TOTAL PROTEIN